奎斯特诊疗（Quest Diagnostics）今日盘中大涨5.02%，股价表现引人注目。此次上涨主要受到公司发布的第二季度财报以及上调全年业绩指引的利好消息推动。
据公司公布的财报显示，奎斯特诊疗第二季度调整后每股收益为2.62美元，高于分析师平均预期的2.57美元。公司营收同比增长15.2%，达到27.6亿美元，同样超过了分析师预期的27.2亿美元。强劲的业绩表现反映了市场对公司诊断测试服务的需求持续旺盛。
更为重要的是，奎斯特诊疗上调了2025年全年业绩指引。公司目前预计2025年调整后的每股收益将在9.63美元至9.83美元之间，高于此前预期的9.55美元至9.80美元。同时，公司将全年营收预期上调至108.0亿美元到109.2亿美元之间，高于此前的107.0亿美元到108.5亿美元。公司首席执行官吉姆·戴维斯表示，奎斯特诊疗在继续部署自动化和数字技术的同时，实现了生产率的提高。这一利好消息进一步提振了投资者信心，推动股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.